+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-12-09Number of Pages: 132

Label-free Array Systems Market (Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS), and Quartz Crystal Microbalance; Applications - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis, and Protein Complex and Cascade Analysis; End Users - R&D Laboratories, Contract Research Organizations, Agriculture Research Institutes, and Forensic Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Label-free Array Systems: Snapshot

The growing focus on drug discovery by several pharmaceutical and biotechnology firms has accelerated the uptake of label-free array systems in recent years. Companies are shifting their preference toward label-free array systems due to increasing time and cost pressure with the use of traditional drug discovery methods such as Enzyme Linked Immunosorbent Assays (ELISA), Nuclear Magnetic Resonance (NMR), etc., which are based on the labelled detection technologies. Label-free array systems work on the principle of eliminating the use of heavy florescent and radioactive labels for identification and validation of molecules as drug candidates. According to the research report, the global label-free array systems market is expected to be worth US$1.7 bn by the end of 2024 from US$1.0 bn in 2015. During the forecast years of 2016 and 2024, the overall market is expected to exhibit a CAGR of 5.6%.

array systems market

Label-free Array Systems Market Thrives as Technologies Offer Accurate Results

The global label-free array systems market is primarily being driven by the growing awareness about its advantages over labeled detection technologies. The new-age systems facilitate an understanding of real time kinetics, binding affinity, and other physio-chemical properties of the molecule under study. These factors have cut down the time required for an analysis, thereby reducing the cost of the procedure as the labels are completely removed. The label-free array systems ensure that the properties of the molecule under study remain untouched as against in labelled detection technologies, which tend to interfere with the properties of the molecule, thereby creating a possibility of inaccurate results.

Contract Research Organizations Promise to Boost Uptake of New Technologies

The end users in the global label-free array systems market are research and development laboratories, contract research organizations, agriculture research institutes, and forensic institutes. Of these end users, the research and development laboratories segment accounted for the lion’s share in the global-label free array systems in 2015. The contract research organizations followed this lead closely and is expected to show a rapid growth rate in the coming years as well. The rising expenditure on research and development of new drugs by pharmaceutical and biotechnology companies along with remarkable improvement in label-free detection technologies particularly for drug discovery are expected drive the segment in the coming years.

Persistent Expenditure on Research and Development in North America Lends Impetus to Regional Market

In terms of geography, the global label-free array systems market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Amongst these segments, North America held a leading share in the global market and is expected to show its dominance in the coming years as well. The regional market’s growth will also be driven by growing spending on research and development, increase in the adoptions of new technologies, and emerging of drug discovery industry. Analysts anticipate that Asia Pacific label-free array systems market is also projected to show a promise of growth during the forecast period. Improving GDPs, strengthening economies, and rising expenditure on research and development are expected to fuel the growth of Asia Pacific market in the near future.

The key players operating in the label-free array systems market are market include Biacore, Agilent Technologies, Bio-Rad Laboratories, and Perkin Elmer. Other players include Attana AB, GWC technologies, ForteBio, BiOptix, F. Hoffman LA Roche, among others. The research report profiles these players and provides a thorough analysis of the competitive landscape and their financial outlooks for the coming few years. 

Global Label-free Array Systems: Overview

Label-free array systems are used in the drug discovery industry by pharmaceutical and biotechnology companies, and work on the principles of optical interferometry, refractive index, and impedance based assays, for the identification and validation of the new molecules as the possible drug candidates, without the use of any labels, in real time and high throughput, thus reducing the time and cost of the drug identification and validation process.  This report studies the current scenario as well as future market potential for label-free array systems globally.

The market overview section of the report comprises qualitative analysis of the overall label-free array systems market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics.

Global Label-free Array Systems: Segmentation

The global label-free array systems market has been segmented on the basis of technology, applications and end users. On the basis of technology the global label-free array systems market is further segmented into surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others. The applications have been further segmented into drug discovery, antibody characterization and development, protein interface analysis, protein complex and cascade analysis, and other applications.

On the basis of end users, the global label-free array systems market is segmented into R&D laboratories, contract research organizations, agriculture research institutes among others. The market for these technologies, end users and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (US$ million) for each of these segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.

Global Label-free Array Systems: Regional Outlook

Geographically, the label-free array systems market has been classified into five segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2016 to 2024.

Key players Mentioned in this Report are:

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global label-free array systems market, in terms of percentage share in 2015 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global label-free array systems market such as Biacore, Agilent technologies, Molecular Devices, Perkin Elmer, Attana AB, BiOptix, Inc., GWC Technologies, ForteBio, F. Hoffman LA Roche. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

Global Label-Free Array Systems Market is segmented as follows:

  • Global Label-free Array Systems Market, by Technology
    • Surface Plasmon Resonance (SPR)
    • Bio-layer Interferometry (BLI)
    • Cellular Dielectric Spectroscopy (CDS)
    • Others (Quartz Crystal Microbalance, etc.)
       
  • Global Label-free Array Systems Market, by End Users 
    • R&D Laboratories
    • Contract Research Organizations
    • Agriculture Research Institutes
    • Others (Forensic Institutes, etc.)
       
  • Global Label-free Array Systems Market, by Applications
    • Drug Discovery
    • Antibody Characterization & Development
    • Protein Interface Analysis
    • Protein Complex & Cascade Analysis
    • Others
       
  • Global Label-free Array Systems Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa


 
 
Back To Top